Skip to main content
Signal8

Regencell Bioscience Holdings Ltd (RGC)

Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.

Sector: Medicinal Chemicals & Botanical Products

Industry: Drug Manufacturers - Specialty & Generic

Regencell Bioscience Holdings Limited logo

Regencell Bioscience Holdings Limited

NASDAQ:RGCHealthcare
-11.86%$6.76
AH Close$6.71-0.77%vs close
Mkt Cap$3.35B
Float17.8M
O/S495.88M
Inst Own0.3%
SI2.5%
Dilution
  • AI analysis ›
  • AI analysis ›
  • AI analysis ›
  • AI analysis ›
  • AI analysis ›
  • AI analysis ›
  • AI analysis ›

Recent SEC filings with analysis